In addition to pancreatic cancer, IFN-β induced evident anti-tumor and chemosensitising effects pre-clinically in several other cancer types, e.g. hepatocellular carcinoma and breast cancer [39, 40]. The gene discussed is IFNB1; the disease is breast carcinoma.